Insider · CIK 0001200699

MOORE THOMAS A

Reports to the SEC for 3 companies · NORTH BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001200699

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-07-17	Ayala Pharmaceuticals, Inc.A Award	Former Director	AAward	+11K sh	—	—	176,462
2013-10-22	Ayala Pharmaceuticals, Inc.Common Stock WarrantsM Exercise/Conversion	Former Director	MExercise/Conversion	+20.3K sh	$0.00	+$20.332	20,332
2013-10-22	Ayala Pharmaceuticals, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+40.8K sh	$4.00	+$163K	165,486
2013-05-21	Ayala Pharmaceuticals, Inc.C Conversion	Former Director	CConversion	+4.75M sh	$0.03	+$120K	15,587,888
2013-05-21	Ayala Pharmaceuticals, Inc.Convertible Promissory NoteC Conversion	Former Director	CConversion	—	—	—	0
2013-03-14	Ayala Pharmaceuticals, Inc.OptionA Award	Former Director	AAward	+4M sh	—	—	4,000,000
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−400K sh	—	—	0
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+2.8M sh	—	—	2,798,765
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+191K sh	—	—	191,334
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+400K sh	—	—	400,000
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+7.67M sh	—	—	7,674,512
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−191K sh	—	—	0
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−2.8M sh	—	—	0
2012-07-05	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−7.67M sh	—	—	0
2012-05-18	Ayala Pharmaceuticals, Inc.Convertible Promissory NoteA Award	Former Director	AAward	—	—	—	—
2012-05-18	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+400K sh	—	—	400,000
2012-05-14	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−1.57M sh	—	—	0
2012-05-14	Ayala Pharmaceuticals, Inc.Convertible Promissory NoteD Disposition to Issuer	Former Director	DDisposition to Issuer	—	—	—	—
2012-05-14	Ayala Pharmaceuticals, Inc.A Award	Former Director	AAward	+5.49M sh	—	—	10,842,367
2011-11-08	Ayala Pharmaceuticals, Inc.OptionsA Award	Former Director	AAward	+4.2M sh	—	—	4,200,000
2011-11-08	Ayala Pharmaceuticals, Inc.OptionsA Award	Former Director	AAward	+4M sh	—	—	4,000,000
2011-10-31	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+1.57M sh	—	—	1,568,627
2011-10-31	Ayala Pharmaceuticals, Inc.Convertible Promissory NoteA Award	Former Director	AAward	—	—	—	—
2011-08-29	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	+2.67M sh	—	—	0
2011-08-29	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)A Award	Former Director	AAward	+7.67M sh	—	—	7,674,512
2011-06-24	Ayala Pharmaceuticals, Inc.Common Stock Warrants (right to buy)P Purchase	Former Director	PPurchase	+3.7M sh	$0.03	+$117K	3,698,765
2010-10-14	Ayala Pharmaceuticals, Inc.OptionsA Award	Former Director	AAward	+2M sh	—	—	2,000,000
2010-06-29	Ayala Pharmaceuticals, Inc.A Award	Former Director	AAward	+750K sh	—	—	5,352,171
2010-04-29	Ayala Pharmaceuticals, Inc.J Other	Former Director	JOther	+1.18M sh	$0.17	+$200K	8,585,505
2009-07-21	Ayala Pharmaceuticals, Inc.OptionsA Award	Former Director	AAward	+2.5M sh	—	—	4,900,000
2008-04-04	Ayala Pharmaceuticals, Inc.A Award	Former Director	AAward	+750K sh	—	—	3,425,700
2008-02-01	Ayala Pharmaceuticals, Inc.J Other	Former Director	JOther	+9,033 sh	—	—	2,675,700
2005-06-29	Synvista Therapeutics, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	75,000
2003-08-07	BIOPURE CORPS Sale	Director, President, CEO	SSale	−8,750 sh	$2.42	−$21.2K	322,862
2003-08-05	BIOPURE CORPWarrant-Common StockS Sale	Director, President, CEO	SSale	−3,500 sh	—	—	37,822
2003-01-23	Synvista Therapeutics, Inc.P Purchase	Director	PPurchase	+1,200 sh	$2.90	+$3,480	23,900
2003-01-23	Synvista Therapeutics, Inc.P Purchase	Director	PPurchase	+100 sh	$2.95	+$295	24,000
2003-01-23	Synvista Therapeutics, Inc.P Purchase	Director	PPurchase	+2,900 sh	$2.96	+$8,584	21,400
2003-01-23	Synvista Therapeutics, Inc.P Purchase	Director	PPurchase	+4,500 sh	$3.00	+$13.5K	18,500
2003-01-23	Synvista Therapeutics, Inc.P Purchase	Director	PPurchase	+1,300 sh	$2.99	+$3,887	22,700
2001-11-27	Synvista Therapeutics, Inc.A Award	Director	AAward	−14K sh	—	—	14,000

Recent filings

Accepted (ET)
Jul 184
Advaxis, Inc.0001493152-14-002216
SEC(opens sec.gov)
Oct 284
Advaxis, Inc.0001144204-13-057258
SEC(opens sec.gov)
Jul 104
Advaxis, Inc.0001144204-13-039032
SEC(opens sec.gov)
Jul 94
MOORE THOMAS A0001144204-12-038742
SEC(opens sec.gov)
May 224
MOORE THOMAS A0001144204-12-031331
SEC(opens sec.gov)
May 164
MOORE THOMAS A0001144204-12-030168
SEC(opens sec.gov)
Nov 184/A
MOORE THOMAS A0001144204-11-065891
SEC(opens sec.gov)

Companies

Address

C/O ADVAXIS, INC. TECHNOLOGY CTR OF NJ, 675 US HIGHWAY ONE

NORTH BRUNSWICK, NJ, 08902